Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Helius Medical Technologies Inc (HSDT)

Helius Medical Technologies Inc (HSDT)
0.2804 x 42 0.3100 x 10
Post-market by (Cboe BZX)
0.2920 -0.0040 (-1.35%) 04/25/25 [NASDAQ]
0.2804 x 42 0.3100 x 10
Post-market 0.2885 -0.0035 (-1.20%) 17:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.2803
Day High
0.3100
Open 0.3100
Previous Close 0.2960 0.2960
Volume 83,300 83,300
Avg Vol 79,170 79,170
Stochastic %K 26.57% 26.57%
Weighted Alpha -90.20 -90.20
5-Day Change +0.0170 (+6.18%) +0.0170 (+6.18%)
52-Week Range 0.2600 - 4.6892 0.2600 - 4.6892
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,789
  • Shares Outstanding, K 6,127
  • Annual Sales, $ 520 K
  • Annual Income, $ -11,740 K
  • EBIT $ -14 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.27
  • Price/Sales 3.49
  • Price/Cash Flow N/A
  • Price/Book 1.04
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.74
  • Most Recent Earnings $-1.03 on 03/25/25
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -5.49
  • Growth Rate Est. (year over year) +18,296.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2600 +12.31%
on 04/21/25
Period Open: 0.4116
0.4889 -40.27%
on 04/01/25
-0.1196 (-29.06%)
since 03/25/25
3-Month
0.2600 +12.31%
on 04/21/25
Period Open: 0.6850
0.7900 -63.04%
on 01/31/25
-0.3930 (-57.37%)
since 01/24/25
52-Week
0.2600 +12.31%
on 04/21/25
Period Open: 4.4400
4.6892 -93.77%
on 04/26/24
-4.1480 (-93.42%)
since 04/25/24

Most Recent Stories

More News
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target

HSDT : 0.2920 (-1.35%)
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies Provides Update on PoNS Device Pricing and Market Access Efforts

Helius Medical Technologies updates on pricing challenges for its PoNS device and plans a business call today at 9:00am ET.Quiver AI SummaryHelius Medical Technologies, Inc. announced updates regarding...

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

HSDT : 0.2920 (-1.35%)
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

HSDT : 0.2920 (-1.35%)

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

3rd Resistance Point 0.3376
2nd Resistance Point 0.3238
1st Resistance Point 0.3079
Last Price 0.2920
1st Support Level 0.2782
2nd Support Level 0.2644
3rd Support Level 0.2485

See More

52-Week High 4.6892
Fibonacci 61.8% 2.9972
Fibonacci 50% 2.4746
Fibonacci 38.2% 1.9520
Last Price 0.2920
52-Week Low 0.2600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective